Search alternatives:
09 a » 19 a (Expand Search)
decrease » decreased (Expand Search), increase (Expand Search)
Showing 1 - 20 results of 450 for search '(( 50 _ decrease ) OR ((((( 09 a decrease ) OR ( 19 _ decrease ))) OR ( 5 ng decrease ))))', query time: 0.18s Refine Results
  1. 1

    Corrigendum: Decreased interfacial dynamics caused by the N501Y mutation in the SARS-CoV-2 S1 spike:ACE2 complex by Wesam S. Ahmed (10170053)

    Published 2022
    “…<p dir="ltr">Corrigendum: Decreased interfacial dynamics caused by the N501Y mutation in the SARS-CoV-2 S1 spike:ACE2 complex: Frontiers in Molecular Biosciences <a href="https://dx.doi.org/10.3389/fmolb.2022.846996" target="_blank">https://dx.doi.org/10.3389/fmolb.2022.846996</a>, published online 22 July 2022.…”
  2. 2

    Nebulized fentanyl for respiratory symptoms in patients with COVID-19 (ventanyl trial) by Nissar Shaikh (11659441)

    Published 2022
    “…<p dir="ltr">Patients with coronavirus disease (COVID-19) commonly experience distressing and challenging respiratory symptoms. …”
  3. 3

    Decreased Interfacial Dynamics Caused by the N501Y Mutation in the SARS-CoV-2 S1 Spike:ACE2 Complex by Wesam S. Ahmed (10170053)

    Published 2022
    “…</p><p dir="ltr">Corrigendum: Decreased interfacial dynamics caused by the N501Y mutation in the SARS-CoV-2 S1 spike:ACE2 complex: Frontiers in Molecular Biosciences: <a href="https://dx.doi.org/10.3389/fmolb.2022.1018464" rel="noreferrer" target="_blank">https://dx.doi.org/10.3389/fmolb.2022.1018464</a>, published online 19 October 2022.…”
  4. 4
  5. 5

    Follow up and comparative assessment of IgG, IgA, and neutralizing antibody responses to SARS-CoV-2 between mRNA-vaccinated naïve and unvaccinated naturally infected individuals ov... by Salma, Younes

    Published 2023
    “…ConclusionThese findings have important implications for policymakers in the development of vaccination strategies, particularly in the consideration of booster doses to sustain long-lasting protection against COVID-19.…”
    Get full text
    Get full text
    Get full text
    article
  6. 6
  7. 7

    Ecotoxicological Assessment of Thermally- and Hydrogen-Reduced Graphene Oxide/TiO<sub>2</sub> Photocatalytic Nanocomposites Using the Zebrafish Embryo Model by Halema Al-Kandari (6316961)

    Published 2019
    “…For the RGOTi, the no observed effect concentration (NOEC, mortality/teratogenicity score <20%) and the median lethal concentration (LC<sub>50</sub>) were <400 and 748.6 mg/L, respectively. …”
  8. 8
  9. 9

    Effects of COVID-19 on Autism Spectrum Disorder in Qatar by Fouad A. Alshaban (17281108)

    Published 2024
    “…Parents also reported decreased access to family and social support networks, as well as decreased quality of clinical and community support. …”
  10. 10

    A BRET-based Mpro biosensor containing a nanobody and tandem cleavage sites shows an increased cleavage rate by Geethakumari, Anupriya M

    Published 2025
    “…We envisage that the NB2E3 nanobody-2× Mpro biosensor engineered here will be useful in drug discovery and functional characterization of Mpro mutants in newly emerging SARS-CoV-2 variants as well as in detecting SARS-CoV-2 infection in a point-of-care testing (POCT) format.…”
    Get full text
    Get full text
    Get full text
    article
  11. 11

    Changes in Physical Activity and Sedentary Behavior Amid Confinement: The BKSQ-COVID-19 Project by Mahmoud A Alomari (12150939)

    Published 2020
    “…<h3>Background</h3><p dir="ltr">Coronavirus disease 19 (COVID-19) has compelled implementing confine ment measure across the globe. …”
  12. 12

    Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021 by Nicholas, Steel

    Published 2025
    “…Deaths from cardiovascular diseases were the primary driver of reductions in life expectancy improvements during 2011–19, and deaths from respiratory infections and other COVID-19 pandemic-related outcomes were responsible for the decreases in life expectancy during 2019–21. …”
    Get full text
    Get full text
    Get full text
    article
  13. 13

    The impact of COVID‐19 pandemic lockdown on smoking habits and lifestyle: A cross‐sectional study by Almu'atasim Khamees (11875640)

    Published 2023
    “…<h3>Background and Aims</h3><p dir="ltr">Throughout the COVID‐19 lockdown, the resultant psychological disturbances led to more tobacco consumption and deteriorated smoking behaviors among smokers. …”
  14. 14

    Economic consequences of the covid 19 outbreak by Sidik, Hanan

    Published 2021
    “…This report is about economic consequences of the covid-19 and all the rules and regulations that have to apply for all citizens. …”
    Get full text
  15. 15

    Predictors of mortality and morbidity in critically ill COVID‐19 patients: An experience from a low mortality country by Mohamad Y. Khatib (11659459)

    Published 2022
    “…</p><h3>Results</h3><p dir="ltr">Between March 7 and July 16, 2020, a total of 1079 patients with COVID-19 were admitted to the ICU. The median (IQR) age of patients was 50 (41–59) years. …”
  16. 16

    Soluble ACE2 and angiotensin II levels are modulated in hypertensive COVID-19 patients treated with different antihypertension drugs by Mohamed A. Elrayess (21398687)

    Published 2022
    “…<h3>Purpose</h3><p dir="ltr">This study examines the effect of antihypertensive drugs on ACE2 and Angiotensin II levels in hypertensive COVID-19 patients.</p><h3>Introduction</h3><p dir="ltr">Hypertension is a common comorbidity among severe COVID-19 patients. …”
  17. 17

    Impact of the COVID-19 lockdown on lifestyle behaviors and their association with personality among adults in Qatar: A cross-sectional study by Tamara Al-Abdi (8710488)

    Published 2022
    “…<p dir="ltr">The coronavirus pandemic (COVID-19) resulted in lockdowns and social distancing measures enforced by governments around the world. …”
  18. 18
  19. 19

    From COVID-19 to clot: the involvement of the complement system by Mohamed A. Hendaus (9401919)

    Published 2020
    “…Low molecular weight heparin for all (unless contraindicated) hospitalized COVID-19 patients can be lifesaving. Agents that inhibit the terminal events of the complement cascade might be crucial for ensuring an efficient treatment, decrease clots and permit early discharge in relation to COVID-19.…”
  20. 20

    COVID-19 biomarkers for severity mapped to polycystic ovary syndrome by Abu Saleh Md Moin (6189512)

    Published 2020
    “…<p dir="ltr">Large scale multi-omics analysis has identified significant differences in the biomarkers between COVID-19 disease and control subjects [1]. These protein panels target biological processes involved in vessel damage, platelet degranulation, the coagulation cascade and the acute phase response [1], with greater protein changes dependent on the COVID-19 severity. …”